Skip to main content
Clinical Trials/NCT06512506
NCT06512506
Recruiting
Not Applicable

Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia

Peking University Third Hospital1 site in 1 country47 target enrollmentJanuary 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Developmental Dysplasia of the Hip
Sponsor
Peking University Third Hospital
Enrollment
47
Locations
1
Primary Endpoint
Improved Harris hip score
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

On the basis of the database established in the previous stage, a cohort analysis was conducted on patients with BDDH complicated by hip arthroscopy for minimally invasive treatment of glenoid and lip injury, according to which the indications of minimally invasive surgery for BDDH patients were optimized and surgical measures were improved. Achieve accurate and rapid repair, rehabilitation and functional recovery, serve national fitness, and treat people's injuries

Detailed Description

Based on the work of the previous research group, we prospective constructed a bidirectional cohort of patients with critical hip dysplasia, and summarized the influencing factors for the surgical prognosis of patients with BDDH, so as to continuously optimize patient selection. On this basis, the cohort size was extended to analyze the difference in efficacy between arthroscopic glenolabial repair and glenolabial repair combined with soft tissue enhancement, and further improve the minimally invasive surgery to promote the efficacy of minimally invasive surgery in BDDH patients

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
December 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of borderline hip dysplasia with glenolabial injury.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Improved Harris hip score

Time Frame: Preoperative, 24 months after surgery

It is suitable for the evaluation of therapeutic effect of various hip diseases. The Harris score includes pain, function, deformity and range of motion. The lower the improved Harris score, the worse the postoperative effect.

PRO rating

Time Frame: Preoperative, 24 months after surgery

Based on Patient-Reported Outcome (PRO) : Questionnaires were completed through face-to-face or telephone interviews. Patients' symptoms, function (activity restriction), pain score, quality of life and time to return to activity were evaluated comprehensively. The lower the PRO score, the worse the postoperative effect.

Cartilage damage outerbridge grading

Time Frame: Preoperative, 24 months after surgery

The patient underwent hip joint MR Examination at 12 months post-operative follow-up with T2 weighted intrachondral defect and high signal

Study Sites (1)

Loading locations...

Similar Trials